Efficacy of pharmacological interventions for ADHD: protocol for an updated systematic review and dose-response network meta-analysis
- PMID: 39396049
- PMCID: PMC11470584
- DOI: 10.1186/s13643-024-02675-1
Efficacy of pharmacological interventions for ADHD: protocol for an updated systematic review and dose-response network meta-analysis
Abstract
Background: Attention-deficit/hyperactivity disorder (ADHD) affects approximately 5% of children globally, with symptoms often persisting into adulthood. While pharmacological interventions are commonly employed for management, understanding the optimal dosing for efficacy and tolerability remains crucial. This study aims to conduct a dose-response network meta-analysis to estimate the efficacy of pharmacological treatments across different doses, aiming to inform clinical decision-making and improve treatment outcomes.
Methods: This updated systematic review will include randomized controlled trials evaluating ADHD medication efficacy in children, adolescents, and adults. An updated search from a 2018 NMA will be conducted across multiple electronic databases with no language restrictions, using specific eligibility criteria focused on randomized controlled trials. The primary outcome will assess the severity of ADHD core symptoms, while secondary outcomes will consider treatment tolerability. A dose-response Bayesian hierarchical model will be used to estimate dose-response curves for each medication, identifying optimal dosing strategies.
Discussion: With this dose-response network meta-analysis, we aim to better understand the dose-response relationship of pharmacological treatment in ADHD, which could help clinician to the identification of optimal doses.
Systematic review registration: OSF https://doi.org/10.17605/OSF.IO/3MY4A .
Keywords: Attention deficit/hyperactivity disorder; Dose-responsenetwork meta-analysis; Pharmacotherapy.
© 2024. The Author(s).
Conflict of interest statement
M. N., L. J., G. S., A. C., F. S., O. E., and T. H. declare that they have no competing interests. S. C. has declared reimbursement for travel and accommodation expenses from the Association for Child and Adolescent Central Health (ACAMH) in relation to lectures delivered for ACAMH, the Canadian AADHD Alliance Resource, the British Association of Psychopharmacology, and from Healthcare Convention for educational activity on ADHD and has received honoraria from Medice
References
-
- American Psychiatric Association. American psychiatric association, éditeurs. diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, D.C: American Psychiatric Association; 2013. p. 947 p.
-
- Faraone SV, Bellgrove MA, Brikell I, Cortese S, Hartman CA, Hollis C, et al. Attention-deficit/hyperactivity disorder. Nat Rev Dis Primer. 2024;10(1):11. - PubMed
-
- Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159–65. - PubMed
-
- Cipriani A, Higgins JPT, Geddes JR, Salanti G. Conceptual and technical challenges in network meta-analysis. Ann Intern Med. 2013;159(2):130. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
